IQVIA is a prominent company in the Business Services sector, specifically focusing on Custom Software and IT Services, as well as the Biotech and Pharmaceuticals industries. Established in 2016 and headquartered in the United States, IQVIA employs over 10,000 individuals and generates significant revenue. The company’s published documents reflect a strong emphasis on research and analysis within the life sciences, particularly concerning drug safety, regulatory scrutiny in clinical trials, and the integration of patient perspectives in medicine access decisions. Their document corpus includes a variety of formats such as research articles, white papers, guides, and case studies. Key themes include the exploration of microbiome therapeutics, real-world evidence generation, and the challenges faced by mid-sized pharmaceutical companies. Additionally, IQVIA addresses the role of artificial intelligence and machine learning in patient analytics and research, highlighting their commitment to advancing healthcare through data-driven insights and innovative methodologies. Overall, IQVIA's publications illustrate their expertise in navigating complex challenges in the healthcare landscape while promoting patient-centric approaches.